Zacks Investment Research on MSN

IBRX responds to FDA warning over misleading cancer drug claims

ImmunityBio IBRX announced its response to a warning letter issued by the FDA last month over “false” or “misleading” promotional statements related to its cancer drug, Anktiva. ImmunityBio stated ...
Regulatory Affairs Professionals Society

FDA warning letters target marketers of unapproved weight loss drugs

In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after ...
U.S. News & World Report

FTC Chairman Issues Non-Compete Warning Letters to Healthcare Employers, Staffing Companies

(Reuters) -Federal Trade Commission Chairman Andrew Ferguson has sent letters to several large healthcare employers and staffing companies to conduct a comprehensive review of their employment ...
WLWT

FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects

The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of Ozempic and Wegovy, alleging the drugmaker failed to report potential side effects in patients who ...
Seeking Alpha

Protagenic Therapeutics receives Nasdaq non-compliance letter

Protagenic Therapeutics (PTIX) has received a notification letter from Nasdaq indicating its non-compliance with the exchange’s listing rules, namely the minimum stockholders' equity requirement and ...
KCCI Des Moines

FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects

As demand for GLP-1 weight loss drugs skyrockets, so does the risk of getting scammed. What we've been seeing in our scam tracker is advertisements about supplements that work just as well as *** ...